annual CFI:
-$1.57B+$413.99M(+20.86%)Summary
- As of today (June 14, 2025), GSK annual cash flow from investing activities is -$1.57 billion, with the most recent change of +$413.99 million (+20.86%) on December 31, 2024.
- During the last 3 years, GSK annual CFI has risen by +$873.99 million (+35.75%).
- GSK annual CFI is now -117.02% below its all-time high of $9.23 billion, reached on December 31, 2015.
Performance
GSK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$1.44B-$12.88M(-0.90%)Summary
- As of today (June 14, 2025), GSK quarterly cash flow from investing activities is -$1.44 billion, with the most recent change of -$12.88 million (-0.90%) on March 31, 2025.
- Over the past year, GSK quarterly CFI has dropped by -$1.25 billion (-662.18%).
- GSK quarterly CFI is now -113.40% below its all-time high of $10.75 billion, reached on March 31, 2015.
Performance
GSK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$2.82B-$1.25B(-79.68%)Summary
- As of today (June 14, 2025), GSK TTM cash flow from investing activities is -$2.82 billion, with the most recent change of -$1.25 billion (-79.68%) on March 31, 2025.
- Over the past year, GSK TTM CFI has dropped by -$1.14 billion (-68.21%).
- GSK TTM CFI is now -129.64% below its all-time high of $9.52 billion, reached on March 31, 2015.
Performance
GSK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GSK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | -662.2% | -68.2% |
| 3 y3 years | +35.8% | +70.1% | +60.8% |
| 5 y5 years | +77.0% | -1837.7% | -60.1% |
GSK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.5% | -248.1% | +70.1% | -646.8% | +74.0% |
| 5 y | 5-year | -156.6% | +85.5% | -141.0% | +70.1% | -201.4% | +74.0% |
| alltime | all time | -117.0% | +85.5% | -113.4% | +72.0% | -129.6% | +74.0% |
GSK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.44B(+0.9%) | -$2.82B(+79.7%) |
| Dec 2024 | -$1.57B(-20.9%) | -$1.43B(+54.1%) | -$1.57B(-779.3%) |
| Sep 2024 | - | -$926.64M(-195.3%) | $231.21M(-55.2%) |
| Jun 2024 | - | $972.50M(-614.6%) | $516.10M(-130.8%) |
| Mar 2024 | - | -$188.99M(-150.5%) | -$1.68B(-15.5%) |
| Dec 2023 | -$1.98B(-81.7%) | $374.35M(-158.3%) | -$1.98B(-43.8%) |
| Sep 2023 | - | -$641.75M(-47.5%) | -$3.53B(-52.1%) |
| Jun 2023 | - | -$1.22B(+146.3%) | -$7.38B(+12.8%) |
| Mar 2023 | - | -$495.92M(-57.8%) | -$6.54B(-39.8%) |
| Dec 2022 | -$10.86B(+344.3%) | -$1.17B(-73.8%) | -$10.86B(+6.7%) |
| Sep 2022 | - | -$4.49B(+1076.0%) | -$10.18B(+39.1%) |
| Jun 2022 | - | -$381.49M(-92.1%) | -$7.32B(+1.7%) |
| Mar 2022 | - | -$4.82B(+879.1%) | -$7.20B(+194.5%) |
| Dec 2021 | -$2.44B(-188.1%) | -$492.34M(-69.7%) | -$2.44B(+19.9%) |
| Sep 2021 | - | -$1.63B(+526.8%) | -$2.04B(+105.7%) |
| Jun 2021 | - | -$259.51M(+292.2%) | -$990.95M(-135.6%) |
| Mar 2021 | - | -$66.17M(-23.2%) | $2.78B(+0.3%) |
| Dec 2020 | $2.77B(-140.6%) | -$86.19M(-85.1%) | $2.77B(+28.1%) |
| Sep 2020 | - | -$579.08M(-116.5%) | $2.16B(-10.1%) |
| Jun 2020 | - | $3.51B(-4825.8%) | $2.41B(-236.6%) |
| Mar 2020 | - | -$74.34M(-89.3%) | -$1.76B(-74.2%) |
| Dec 2019 | -$6.84B(+229.9%) | -$695.22M(+106.2%) | -$6.84B(+1.6%) |
| Sep 2019 | - | -$337.19M(-48.6%) | -$6.73B(-4.1%) |
| Jun 2019 | - | -$655.45M(-87.3%) | -$7.01B(+4.6%) |
| Mar 2019 | - | -$5.15B(+776.9%) | -$6.70B(+223.6%) |
| Dec 2018 | -$2.07B(+11.2%) | -$587.09M(-5.7%) | -$2.07B(+9.2%) |
| Sep 2018 | - | -$622.40M(+79.5%) | -$1.90B(-0.1%) |
| Jun 2018 | - | -$346.72M(-32.8%) | -$1.90B(-10.9%) |
| Mar 2018 | - | -$515.88M(+25.0%) | -$2.13B(+14.5%) |
| Dec 2017 | -$1.86B(+8.4%) | -$412.75M(-33.9%) | -$1.86B(+7.6%) |
| Sep 2017 | - | -$624.61M(+7.8%) | -$1.73B(+41.7%) |
| Jun 2017 | - | -$579.33M(+135.1%) | -$1.22B(+20.9%) |
| Mar 2017 | - | -$246.47M(-12.3%) | -$1.01B(-41.2%) |
| Dec 2016 | -$1.72B(-118.6%) | -$281.06M(+143.7%) | -$1.72B(-22.7%) |
| Sep 2016 | - | -$115.35M(-68.7%) | -$2.23B(-1.5%) |
| Jun 2016 | - | -$368.14M(-61.4%) | -$2.26B(-8.8%) |
| Mar 2016 | - | -$954.82M(+21.3%) | -$2.48B(-126.8%) |
| Dec 2015 | $9.23B(-619.2%) | -$787.36M(+430.8%) | $9.23B(-1.9%) |
| Sep 2015 | - | -$148.34M(-74.7%) | $9.40B(+2.2%) |
| Jun 2015 | - | -$585.19M(-105.4%) | $9.20B(-3.4%) |
| Mar 2015 | - | $10.75B(-1862.0%) | $9.52B(-635.9%) |
| Dec 2014 | -$1.78B(-316.7%) | -$609.93M(+72.2%) | -$1.78B(-206.1%) |
| Sep 2014 | - | -$354.19M(+36.1%) | $1.67B(+39.3%) |
| Jun 2014 | - | -$260.20M(-52.9%) | $1.20B(+64.6%) |
| Mar 2014 | - | -$552.63M(-119.4%) | $730.11M(-10.9%) |
| Dec 2013 | $819.84M(-119.7%) | $2.84B(-443.6%) | $819.84M(-133.7%) |
| Sep 2013 | - | -$827.03M(+13.0%) | -$2.43B(-55.0%) |
| Jun 2013 | - | -$732.11M(+58.2%) | -$5.41B(+11.3%) |
| Mar 2013 | - | -$462.90M(+13.0%) | -$4.86B(+16.5%) |
| Dec 2012 | -$4.17B(+2221.4%) | -$409.51M(-89.2%) | -$4.17B(-7.5%) |
| Sep 2012 | - | -$3.80B(+1972.7%) | -$4.51B(+315.4%) |
| Jun 2012 | - | -$183.44M(-181.1%) | -$1.08B(-16.0%) |
| Mar 2012 | - | $226.19M(-130.3%) | -$1.29B(+618.9%) |
| Dec 2011 | -$179.59M | -$746.38M(+95.9%) | -$179.59M(-35.3%) |
| Sep 2011 | - | -$381.08M(-2.2%) | -$277.50M(-59.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | -$389.75M(-129.1%) | -$685.68M(-33.9%) |
| Mar 2011 | - | $1.34B(-258.4%) | -$1.04B(-64.0%) |
| Dec 2010 | -$2.88B(-54.2%) | -$844.28M(+7.0%) | -$2.88B(-0.9%) |
| Sep 2010 | - | -$789.26M(+6.5%) | -$2.91B(-52.6%) |
| Jun 2010 | - | -$740.97M(+46.7%) | -$6.13B(+5.0%) |
| Mar 2010 | - | -$505.23M(-41.9%) | -$5.83B(-7.2%) |
| Dec 2009 | -$6.29B(+195.8%) | -$869.75M(-78.3%) | -$6.29B(-8.1%) |
| Sep 2009 | - | -$4.01B(+797.0%) | -$6.84B(+110.6%) |
| Jun 2009 | - | -$447.25M(-53.3%) | -$3.25B(+25.5%) |
| Mar 2009 | - | -$957.18M(-32.7%) | -$2.59B(+21.8%) |
| Dec 2008 | -$2.12B(-64.7%) | -$1.42B(+237.4%) | -$2.12B(-38.1%) |
| Sep 2008 | - | -$421.29M(-298.3%) | -$3.43B(-9.2%) |
| Jun 2008 | - | $212.41M(-143.0%) | -$3.78B(-18.7%) |
| Mar 2008 | - | -$494.38M(-81.9%) | -$4.65B(-22.8%) |
| Dec 2007 | -$6.03B(+115.0%) | -$2.73B(+255.3%) | -$6.03B(+35.5%) |
| Sep 2007 | - | -$768.57M(+16.6%) | -$4.45B(-4.7%) |
| Jun 2007 | - | -$659.26M(-64.7%) | -$4.67B(+6.6%) |
| Mar 2007 | - | -$1.87B(+62.3%) | -$4.38B(+56.1%) |
| Dec 2006 | -$2.80B(-7.2%) | -$1.15B(+16.7%) | -$2.80B(-54.2%) |
| Sep 2006 | - | -$986.11M(+166.1%) | -$6.11B(+81.6%) |
| Jun 2006 | - | -$370.62M(+25.4%) | -$3.37B(-2.9%) |
| Mar 2006 | - | -$295.50M(-93.4%) | -$3.47B(+14.9%) |
| Dec 2005 | -$3.02B(+79.2%) | -$4.46B(-353.4%) | -$3.02B(-364.1%) |
| Sep 2005 | - | $1.76B(-472.9%) | $1.14B(-189.2%) |
| Jun 2005 | - | -$472.23M(-408.3%) | -$1.28B(+1.3%) |
| Mar 2005 | - | $153.16M(-151.3%) | -$1.27B(-24.9%) |
| Dec 2004 | -$1.69B(+9.8%) | -$298.59M(-55.1%) | -$1.69B(-19.0%) |
| Sep 2004 | - | -$664.37M(+45.6%) | -$2.08B(+15.4%) |
| Jun 2004 | - | -$456.31M(+71.3%) | -$1.80B(+14.6%) |
| Mar 2004 | - | -$266.37M(-61.6%) | -$1.57B(+2.5%) |
| Dec 2003 | -$1.53B(-6.1%) | -$692.91M(+79.1%) | -$1.53B(+2.5%) |
| Sep 2003 | - | -$386.79M(+70.1%) | -$1.50B(-1.9%) |
| Jun 2003 | - | -$227.36M(-0.2%) | -$1.53B(-5.7%) |
| Mar 2003 | - | -$227.83M(-65.3%) | -$1.62B(-1.0%) |
| Dec 2002 | -$1.64B(-53.5%) | -$655.92M(+57.6%) | -$1.64B(-48.7%) |
| Sep 2002 | - | -$416.17M(+30.4%) | -$3.19B(-10.4%) |
| Jun 2002 | - | -$319.12M(+30.8%) | -$3.55B(+8.7%) |
| Mar 2002 | - | -$243.90M(-89.0%) | -$3.27B(-7.0%) |
| Dec 2001 | -$3.52B(+379.3%) | -$2.21B(+181.5%) | -$3.52B(+72.2%) |
| Sep 2001 | - | -$784.33M(+2223.2%) | -$2.04B(+100.7%) |
| Jun 2001 | - | -$33.76M(-93.1%) | -$1.02B(-334.2%) |
| Mar 2001 | - | -$490.58M(-33.1%) | $434.37M(-159.2%) |
| Dec 2000 | -$733.60M(-49.4%) | -$733.60M(-405.1%) | -$733.60M(<-9900.0%) |
| Sep 2000 | - | $240.46M(-83.0%) | $0.00(-100.0%) |
| Jun 2000 | - | $1.42B(-185.5%) | -$240.46M(-85.5%) |
| Mar 2000 | - | -$1.66B | -$1.66B |
| Dec 1999 | -$1.45B(+5.4%) | - | - |
| Dec 1998 | -$1.38B(+27.8%) | - | - |
| Dec 1997 | -$1.08B(+562.6%) | - | - |
| Dec 1996 | -$162.44M(-97.9%) | - | - |
| Dec 1995 | -$7.57B(+1.0%) | - | - |
| Jun 1995 | -$7.49B(+267.0%) | - | - |
| Jun 1994 | -$2.04B(+46.3%) | - | - |
| Jun 1993 | -$1.39B(+113.1%) | - | - |
| Jun 1992 | -$654.38M(-58.6%) | - | - |
| Jun 1991 | -$1.58B | - | - |
FAQ
- What is GSK annual cash flow from investing activities?
- What is the all time high annual CFI for GSK?
- What is GSK annual CFI year-on-year change?
- What is GSK quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for GSK?
- What is GSK quarterly CFI year-on-year change?
- What is GSK TTM cash flow from investing activities?
- What is the all time high TTM CFI for GSK?
- What is GSK TTM CFI year-on-year change?
What is GSK annual cash flow from investing activities?
The current annual CFI of GSK is -$1.57B
What is the all time high annual CFI for GSK?
GSK all-time high annual cash flow from investing activities is $9.23B
What is GSK annual CFI year-on-year change?
Over the past year, GSK annual cash flow from investing activities has changed by +$413.99M (+20.86%)
What is GSK quarterly cash flow from investing activities?
The current quarterly CFI of GSK is -$1.44B
What is the all time high quarterly CFI for GSK?
GSK all-time high quarterly cash flow from investing activities is $10.75B
What is GSK quarterly CFI year-on-year change?
Over the past year, GSK quarterly cash flow from investing activities has changed by -$1.25B (-662.18%)
What is GSK TTM cash flow from investing activities?
The current TTM CFI of GSK is -$2.82B
What is the all time high TTM CFI for GSK?
GSK all-time high TTM cash flow from investing activities is $9.52B
What is GSK TTM CFI year-on-year change?
Over the past year, GSK TTM cash flow from investing activities has changed by -$1.14B (-68.21%)